Other specified/unspecified diseases of inner ear

H8_INNERNAS

inner ear disease: A non-neoplastic or neoplastic disorder affecting the inner ear. Causes are inner ear infections, head injuries, and neoplasms (e.g., acoustic schwannoma). Symptoms include dizziness, imbalance, nausea, and vision problems. [database_cross_reference: NCIT:C27166]

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H83.8, H83.9 Cause of death: ICD-10 — H83.8, H83.9 2 out of 7 registries used, show all original rules.	177
4. Check minimum number of events None	177
5. Include endpoints None	177
6. Filter based on genotype QC (FinnGen only)	177

Control definitions (FinnGen only)

Control exclude: H8_INNER

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	H8_INNERNAS
CONTROL_EXCLUDE	H8_INNER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H83[8-9]
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H83[8-9]
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other specified/unspecified diseases of inner ear based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1376	700	666
Only index persons	1255	656	599
Unadjusted period prevalence (%)
Whole population	0.02	0.02	0.02
Only index persons	0.02	0.02	0.02
Median age at first event (years)
Whole population	68.30	67.86	68.62
Only index persons	67.10	67.22	66.97

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	177	82	95
Unadjusted period prevalence (%)	0.04	0.03	0.04
Median age at first event (years)	64.64	58.33	70.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
158: Matched controls
1580

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H83.9

ICD-10 Finland

Disease of inner ear, unspecified

+∞

164.8

128

Z01.1

ICD-10 Finland

Examination of ears and hearing

15.9

47.7

121

H83.8

ICD-10 Finland

Other specified diseases of inner ear

+∞

33.5

Z97.4

ICD-10 Finland

Presence of external hearing-aid

17.7

30.9

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

11.7

27.6

R5599

NOMESCO Finland

Other rehabilitation service

34.1

27.2

DFF00

NOMESCO Finland

Pure tone audiometry

11.0

24.2

Z3229

NOMESCO Finland

Other healthcare associate professional

9.2

23.3

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

10.5

21.4

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

7.0

18.7

101

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

14.7

14.5

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

4.6

13.6

160

N07CA01

ATC

betahistine; oral

6.8

13.1

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

7.8

12.8

R1260

NOMESCO Finland

Evaluation of communicative skills

23.6

12.3

TDA90

NOMESCO Finland

Removal wax from ear

32.9

11.9

RD211

NOMESCO Finland

11.9

11.1

DFF15

NOMESCO Finland

Speech audiometry

8.8

10.8

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

9.3

10.7

UDC00

NOMESCO Finland

Ear microscopy

6.5

9.4

R5140

NOMESCO Finland

Monitoring the use of the aid

4.8

8.9

Z3231

NOMESCO Finland

Registered nurse

3.0

8.9

304

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

11.0

8.8

H81.0

ICD-10 Finland

Ménière disease

83.8

7.5

Z00.0

ICD-10 Finland

General medical examination

3.2

7.3

167

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

10.8

7.2

R5120

NOMESCO Finland

Preparation of an aid

10.8

7.2

Z71.8

ICD-10 Finland

Other specified counselling

2.9

7.0

194

H13

ICPC

Plugged feeling ear

3.1

6.9

149

WNF00

NOMESCO Finland

Infection source and contact determination

41.9

6.8

SAA01

NOMESCO Finland

Simple examination of mouth

2.4

6.6

103

689

R42

ICD-10 Finland

Dizziness and giddiness

2.8

6.5

202

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

2.9

6.4

175

XCD10

NOMESCO Finland

Electrophysiological examination of eye

8.2

6.3

DAX08

NOMESCO Finland

Fitting of hearing aid

5.8

6.0

H91.9

ICD-10 Finland

Hearing loss, unspecified

6.3

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3021589) Normoblasts [#/volume] in Blood

569

2.18

6.08

9.1

8.9

e9/l

0.0

0.53

468

(3002385) Erythrocyte distribution width [Ratio]

134

1049

2.14

4.56

20.7

18.3

13.8

0.28

128

1027

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

262

2.08

4.15

3.9

2.8

ug/l

0.9

0.7

0.51

172

(3002179) Metamyelocytes/100 leukocytes in Blood

2.53

3.58

3.1

4.2

—

0.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

7.71

3.08

1.0

1.3

—

(3018010) Neutrophils/100 leukocytes in Blood

617

1.69

2.93

5.0

5.3

56.3

58.4

0.72

576

(3022096) Basophils/100 leukocytes in Blood

601

1.68

2.87

4.6

5.3

0.7

0.6

0.87

554

(3006504) Eosinophils/100 leukocytes in Blood

611

1.67

2.85

4.8

5.3

2.9

2.8

0.18

563

(3035320) C reactive protein [Mass/volume] in Body fluid

8.53

2.76

1.8

1.2

—

(3019069) Monocytes/100 leukocytes in Blood

616

1.65

2.74

5.2

5.6

8.6

8.7

0.14

575

(3002030) Lymphocytes/100 leukocytes in Blood

627

1.65

2.70

4.9

5.5

28.9

26.5

0.90

580

(3021440) Promyelocytes/100 leukocytes in Blood

103

2.18

2.54

3.1

4.4

—

0.1

—

(3030467) Casts [#/volume] in Urine by Automated count

375

1.68

2.47

4.5

3.1

e6/l

0.6

0.4

0.25

282

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

171

0.33

2.44

5.8

4.6

32.3

31.6

—

110

(36304419) Bacteria [Presence] in Urine

369

1.67

2.40

4.5

3.0

—

(3026782) Osmolality of Urine

278

1.72

2.33

2.6

2.9

mosm/kgh2o

556.8

561.7

0.05

240

(3002582) Erythrocytes [#/volume] in Urine

425

1.62

2.30

4.3

3.2

e6/l

60.2

179.4

0.36

333

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

139

1207

1.71

2.23

17.3

14.6

ml/min/173m2

74.4

77.5

0.86

124

998

(3000850) Epithelial cells [#/volume] in Urine

290

1.69

2.22

2.8

2.7

e6/l

3.4

4.6

0.64

264

(3001604) Monocytes [#/volume] in Blood

649

1.56

2.22

4.5

5.2

e9/l

0.6

0.45

569

(3019198) Lymphocytes [#/volume] in Blood

659

1.56

2.21

4.5

5.4

e9/l

2.1

1.8

0.45

592

(3006315) Basophils [#/volume] in Blood

650

1.56

2.20

4.6

5.2

e9/l

0.0

0.92

571

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

3.10

2.18

1.4

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

2.09

0.0

1.6

—

(40768797) Stomach Pathology biopsy report

172

1.82

2.09

1.4

1.3

—

(3045716) Anion gap in Serum or Plasma

5.11

2.08

1.4

1.7

mmol/l

7.3

9.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

5.11

2.08

1.2

1.1

—

(3007461) Platelets [#/volume] in Blood

156

1409

1.90

2.06

23.9

22.1

e9/l

245.8

244.4

0.10

151

1368

(3010813) Leukocytes [#/volume] in Blood

156

1410

1.90

2.04

23.8

22.1

e9/l

6.9

6.8

0.26

145

1362

(3026361) Erythrocytes [#/volume] in Blood

156

1410

1.90

2.04

23.8

22.1

e12/l

4.4

0.37

145

1363

(3013115) Eosinophils [#/volume] in Blood

669

1.52

2.01

5.0

5.5

e9/l

0.2

0.57

593

(40768804) Tissue Pathology biopsy report

533

1.52

1.91

2.6

2.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

766

1.48

1.82

9.5

8.5

e9/l

4.1

0.09

670

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

163

0.41

1.78

10.0

7.8

—

(3002256) Pathology report gross observation

166

1.74

1.2

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

3.92

1.72

1.2

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

144

1291

1.62

1.71

17.0

15.3

mg/l

25.7

25.1

0.06

131

1049

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2.65

1.68

1.5

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

147

1327

1.64

1.67

18.7

18.0

mmol/l

4.0

0.39

141

1290

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2.76

1.60

1.3

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2.76

1.60

1.3

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

140

1.74

1.54

2.4

ug/g

73.5

155.5

1.05

112

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

3.40

1.53

1.0

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

3.40

1.53

2.4

1.6

—

(3018095) Leukocytes [#/volume] in Urine

489

1.45

1.51

4.6

3.7

e6/l

304.5

81.0

0.45

356

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

137

1228

1.51

1.49

4.6

4.8

mmol/l

6.0

0.02

116

1104

(3044889) 12 lead EKG panel

105

896

1.42

1.48

4.3

4.1

—

(40761511) CBC panel - Blood by Automated count

147

1340

1.57

1.45

13.9

14.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

113

980

1.42

1.43

3.8

4.0

mm/h

12.5

12.6

0.01

107

896

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

141

1275

1.52

1.43

5.0

5.1

mmol/l

2.7

0.37

120

1151

(40760892) CBC W Ordered Manual Differential panel - Blood

287

1.51

1.41

3.8

4.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

161

1.64

1.38

2.5

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

368

1.46

1.38

4.7

4.4

20.3

22.2

0.37

174

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

2.66

1.38

2.3

3.0

u/ml

32.2

19.0

—

(3045424) Erythrocytes [Presence] in Urine

2.99

1.37

1.6

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

2.99

1.37

1.6

57.4

57.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

525

1.41

1.36

2.6

2.3

nmol/l

81.9

75.7

0.84

459

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

229

1.54

1.35

4.1

2.6

e6/l

3.6

0.9

0.37

133

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

134

1206

1.46

1.33

3.9

4.1

mmol/l

1.4

1.3

1.57

115

1079

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

660

1.39

1.33

5.8

6.8

mmol/l

1.2

0.33

557

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.81

1.30

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

137

1241

1.46

1.29

4.4

4.6

mmol/l

1.4

0.83

118

1119

(3045414) Leukocytes [Presence] in Urine

2.10

1.29

2.8

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

2.10

1.29

2.1

3.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

485

1.39

1.25

4.6

3.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

106

923

1.37

1.23

4.4

3.9

pmol/l

14.4

14.8

1.00

101

830

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

2.68

1.22

2.4

1.5

35.6

32.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

252

1.48

1.21

5.3

3.5

ng/l

220.1

369.7

0.33

213

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

114

0.42

1.17

1.8

1.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

216

1.47

1.04

4.4

2.8

e6/l

2.1

1.8

—

121

(3001122) Ferritin [Mass/volume] in Serum or Plasma

564

1.33

1.04

2.7

ug/l

181.3

112.7

0.46

514

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.31

1.04

2.6

4.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

351

1.38

1.02

1.8

1.5

nmol/l

20.4

21.1

0.10

290

(3033658) Prothrombin time (PT) actual/Normal

333

1.38

1.01

4.3

3.8

85.9

87.1

0.10

322

(3014576) Chloride [Moles/volume] in Serum or Plasma

175

1.50

1.00

4.5

5.5

mmol/l

104.7

104.4

0.08

170

(3016879) Cocaine [Presence] in Urine

0.00

0.98

0.0

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.84

0.98

1.4

2.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

0.00

0.98

0.0

1.7

—

5.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.97

0.0

1.3

—

(3013512) EKG study

409

0.71

0.96

4.5

4.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

551

1.32

0.96

2.1

2.0

pmol/l

92.8

94.9

0.15

274

(3000494) Fungus identified in Specimen by Culture

170

1.48

0.91

1.6

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

2.11

0.90

2.5

3.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

162

1.48

0.90

2.6

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

114

1030

1.30

0.89

8.1

7.3

u/l

74.3

78.4

0.48

106

952

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

232

1.41

0.89

2.3

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

461

1.31

0.89

4.4

2.9

mmol/l

2.4

2.3

0.55

395

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

112

1.57

0.88

3.2

3.8

mmol/l

1.2

0.43

102

(3017143) Hepatitis C virus Ab [Presence] in Serum

140

0.55

0.87

1.1

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

745

1.27

0.83

4.0

2.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

162

0.59

0.81

1.4

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

124

0.55

0.81

2.0

1.8

—

(3019225) pH of Specimen

125

0.54

0.81

6.9

4.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.85

0.80

1.2

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

0.00

0.79

0.0

1.7

—

19371.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

583

1.27

0.78

3.7

4.3

g/l

34.6

35.3

0.48

545

(3026008) Bacteria identified in Urine by Culture

413

1.29

0.77

2.3

3.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.79

0.77

1.2

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

125

1157

1.27

0.73

5.6

4.7

mu/l

2.1

1.9

0.63

109

1025

(3024928) Oxygen saturation in Venous blood

2.03

0.73

1.6

2.8

—

(3049717) Cytology report of Urine Cyto stain

1.61

0.72

3.3

2.8

—

(3018418) pH of Serum or Plasma

399

1.28

0.70

4.1

3.9

7.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

127

1181

1.27

0.69

6.3

6.4

mmol/mol

41.5

40.9

0.31

117

1086

(3002032) Base excess in Venous blood by calculation

128

1.45

0.69

1.5

3.9

mmol/l

2.1

1.6

0.11

101

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

253

1.32

0.67

2.4

2.7

mmol/l

2.4

2.5

0.88

223

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.61

0.67

4.5

15.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.81

0.66

1.0

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

130

1.43

0.64

1.6

3.9

kpa

5.7

5.8

0.03

122

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

605

1.23

0.64

3.8

4.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.60

0.0

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.60

0.0

1.1

—

(3021788) Differential panel - Synovial fluid

0.00

0.59

0.0

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.74

0.58

1.7

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.74

0.58

1.0

1.2

—

(3042936) Bacteria identified in Isolate by Culture

205

1.31

0.56

2.1

2.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.52

0.55

1.4

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

0.61

0.54

3.5

3.2

kpa

4.8

5.1

—

(3012544) pH of Venous blood

136

1.36

0.51

1.6

4.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

163

1.33

0.51

3.0

4.1

ug/l

1.9

50.4

0.61

135

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

311

1.24

0.50

2.2

2.3

—

(3036489) Thrombin time

1.54

0.49

1.3

2.1

22.3

21.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

120

1131

1.19

0.47

20.0

16.3

40.0

39.3

0.51

100

800

(3024354) Oxygen [Partial pressure] in Venous blood

112

1.37

0.46

1.4

3.0

kpa

4.1

4.4

0.28

104

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

476

1.19

0.46

7.3

5.1

ug/l

29.2

2.1

0.67

416

(3007164) IgA [Mass/volume] in Serum or Plasma

249

1.25

0.45

1.2

1.4

g/l

2.9

2.6

0.50

156

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1.39

0.44

1.9

2.2

g/l

0.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

325

1.22

0.44

3.1

2.9

umol/l

8676.0

7375.2

0.05

272

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

297

1.22

0.44

1.8

1.7

mg/l

0.9

1.2

0.74

222

(3009343) pH of Capillary blood

0.63

0.43

3.3

—

7.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.63

0.43

1.2

1.6

—

(4010399)

0.62

0.43

1.2

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.45

0.43

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.41

0.0

1.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.41

0.0

3.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

0.00

0.41

0.0

1.1

—

8.0

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.41

0.0

2.9

—

2.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1.48

0.40

2.0

2.6

mg/l

1.4

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

363

0.82

0.40

4.9

3.8

estimate

0.0

0.50

122

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.33

0.40

1.8

2.0

g/l

2.6

3.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.44

0.39

1.0

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

263

1.22

0.39

1.2

u/ml

0.6

2.1

1.13

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.39

0.0

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.39

0.0

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.7

—

(3044941) Cell count panel - Synovial fluid

0.00

0.39

0.0

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.38

0.39

1.3

1.6

—

(40758558) Short blood count panel - Blood

339

1.19

0.39

9.6

6.1

—

(3023368) Bacteria identified in Blood by Culture

406

1.18

0.39

5.5

4.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.40

0.38

1.0

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

116

1.32

0.38

2.3

e9/l

65.7

69.7

—

(3032080) INR in Blood by Coagulation assay

562

1.16

0.38

11.3

9.2

inr

1.3

0.22

167

(42870588) Differential panel, method unspecified - Blood

438

1.16

0.35

4.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

919

0.88

0.35

4.8

4.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

182

1.24

0.35

1.7

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.38

0.35

1.0

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

132

0.74

0.33

4.1

2.2

ug/l

3.5

5.5

—

116

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

568

1.14

0.32

4.0

ng/l

25.9

48.4

1.36

405

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1.31

0.31

1.9

2.1

g/l

0.0

—

(40761535) Cells panel - Urine sediment

108

0.73

0.30

4.3

3.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.26

0.30

1.9

2.1

g/l

42.0

36.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

112

1.27

0.29

2.7

2.1

g/l

66.1

65.8

0.07

(3041096) Erythrocytes [Presence] in Urine by Automated

377

1.15

0.29

3.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.31

0.29

1.5

1.8

—

(3025941) Bacteria identified in Stool by Culture

1.33

0.29

1.0

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.22

0.27

1.8

2.0

g/l

6.7

7.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.22

0.27

1.8

2.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

0.70

0.24

1.2

1.3

—

(3000991) Gas panel - Venous blood

106

1.24

0.24

4.6

7.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.32

0.23

1.8

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.27

0.23

2.5

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

135

0.80

0.22

5.5

3.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.24

0.22

1.7

2.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3035880) pH of Pleural fluid

0.00

0.21

0.0

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.21

0.0

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.21

0.0

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.21

0.0

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

1.8

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

17.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

0.00

0.21

0.0

1.2

—

9.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

0.21

0.0

1.7

—

740.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

357

1.12

0.20

1.9

2.0

mg/l

2.5

3.0

1.14

308

(4062490)

0.00

0.20

0.0

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.20

0.0

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.23

0.20

1.8

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1.19

0.18

1.9

2.1

g/l

0.1

0.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

448

1.10

0.18

3.3

3.0

ng/l

1471.8

1527.5

0.04

377

(3027801) Oxygen [Partial pressure] in Arterial blood

167

1.15

0.17

4.8

8.7

kpa

11.0

11.4

0.18

161

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

167

1.15

0.17

4.8

8.7

kpa

5.3

5.1

0.64

160

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.13

0.17

1.9

2.0

g/l

8.9

10.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.15

0.16

1.6

2.8

0.7

1.2

—

(36660697) Celiac disease serology panel - Serum

1.21

0.16

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

102

1.19

0.15

1.8

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

285

1.11

0.15

3.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.13

0.15

1.6

2.4

—

(3015736) pH of Urine

511

1.08

0.15

3.4

3.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

189

1.13

0.14

1.6

1.4

—

(21494755) Public health laboratory ask at order entry panel

0.82

0.14

1.3

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

424

1.08

0.14

2.5

2.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

827

0.94

0.12

2.9

3.1

u/l

41.6

50.0

0.89

776

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

126

0.86

0.11

1.5

2.2

g/l

0.2

0.09

113

(3021601) Nitrite [Presence] in Urine by Test strip

645

1.06

0.11

5.7

5.2

estimate

0.0

0.50

128

(3022948) Iron [Moles/volume] in Serum or Plasma

231

1.10

0.11

1.8

2.3

umol/l

13.6

13.3

0.06

204

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.14

0.10

1.2

1.8

—

(3003694) ABO and Rh group [Type] in Blood

322

1.07

0.09

1.3

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.81

0.08

1.0

1.9

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

0.83

0.08

3.4

1.7

ug/l

2.9

5.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

0.80

0.08

1.2

2.0

u/l

39.8

42.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

0.82

0.08

7.3

5.0

mmol/l

25.0

24.5

—

(4035726)

122

0.90

0.07

1.0

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.02

0.07

1.2

1.3

—

(3019060) Gas panel - Arterial blood

101

0.89

0.06

3.4

8.5

—

(3022621) pH of Urine by Test strip

100

0.89

0.06

2.8

2.6

—

(40761536) Microorganisms panel - Urine sediment

111

0.89

0.06

4.5

3.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

209

1.06

0.04

1.3

1.2

u/ml

0.7

15.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

331

0.96

0.04

1.9

1.6

mmol/l

1.3

0.00

278

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

220

0.95

0.04

1.2

iu/ml

17.6

40.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

171

1.06

0.03

1.7

1.5

—

(3009261) Glucose [Presence] in Urine by Test strip

659

1.03

0.03

4.1

3.8

estimate

0.0

0.00

125

(3020682) Albumin/Creatinine [Ratio] in Urine

410

0.97

0.03

4.1

3.9

mg/mmol

8.9

8.4

0.03

265

(3022217) INR in Platelet poor plasma by Coagulation assay

198

0.95

0.02

22.5

27.8

inr

1.0

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

416

0.98

0.00

4.3

3.0

u/l

28.9

33.8

0.74

391

(46235355) HIV 1 and 2 tests - Meaningful Use set

196

1.02

0.00

1.5

1.6

—

(3019150) Specific gravity of Urine by Refractometry

294

0.98

0.00

4.1

3.9

kg/l

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

519

1.00

0.00

4.2

3.9

—

(3035350) Ketones [Presence] in Urine by Test strip

649

1.00

0.00

4.2

3.7

estimate

0.0

0.00

131

(3022145) Colonoscopy Study observation

147

1.02

0.00

1.5

1.3

—

(3012516) Albumin [Mass/volume] in Urine

383

0.99

0.00

3.4

3.0

mg/l

58.6

215.3

0.48

259

(3009508) Creatinine [Moles/volume] in Urine

395

0.98

0.00

3.2

2.9

mmol/l

7.5

7.9

0.23

326

(1761868) Lipid panel - Serum or Plasma

422

0.99

0.00

2.5

3.2

—

(3000492) Spirometry study

118

1.02

0.00

1.4

—

(3000330) Specific gravity of Urine by Test strip

0.92

0.00

3.0

3.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.0

1.3

—

(3020891) Body temperature

0.94

0.00

4.6

4.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.00

0.0

2.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

0.0

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

12.7

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

0.0

3.3

—

56.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

0.0

2.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.86

0.00

1.0

1.8

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.0

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

0.0

4.3

—

57.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

6.3

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.0

5.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

18.2

—

1165.8

—

(3015183) Erythrocyte sedimentation rate

0.00

0.0

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.0

1.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

18.0

—

570.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

0.00

0.0

2.0

—

(3017704) Immunofixation for Urine

0.00

0.0

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.0

1.4

—

16.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

0.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

4.4

—

(3047189) Immunofixation for 24 hour Urine

0.00

0.0

1.4

—

(3014271) Vancomycin [Susceptibility]

0.00

0.0

2.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

0.86

0.00

1.0

1.3

—

(4146454)

0.00

0.0

3.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(40768443) Skin Pathology biopsy report

0.92

0.00

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.0

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.0

1.8

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

0.00

0.0

10.5

—

0.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3024263) Appearance of Synovial fluid

0.00

0.0

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

0.00

0.0

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

0.0

1.0

—

10.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

0.0

1.9

—

13.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.1

—

(4211845)

0.00

0.0

4.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

4.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(44806071)

0.00

0.0

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

0.0

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.0

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

2.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

0.00

0.0

1.3

—

118.5

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

0.0

1.3

—

1.2

—

(3012565) Volume of 24 hour Urine

0.00

0.0

2.2

—

2107.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

0.00

0.0

1.8

—

16.1

—

(3004451) EKG impression Narrative

0.00

0.0

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.1

—

125.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

34.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

(1002224) Polysomnography panel

1.02

0.00

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

0.0

1.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.01

0.00

1.4

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

5.0

—

210.6

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

1.7

—

1193.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

0.0

1.2

—

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(44806420)

0.00

0.0

2.7

—

(3006462) Nitrate [Presence] in Urine

0.00

0.0

6.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.0

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_INNERNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_INNERNAS	0.994 [0.83, 1.19]	0.949
Birth year	0.992 [0.98, 1.0]	0.078

During the follow-up period (1.1.1998 — 31.12.2019), 195 out of 647 females with H8_INNERNAS died.

Males

Parameter	HR [95% CI]	p-value
H8_INNERNAS	0.865 [0.72, 1.03]	0.111
Birth year	0.984 [0.97, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 211 out of 621 males with H8_INNERNAS died.

Mortality risk

Mortality risk for people of age

years, who have H8_INNERNAS.

N-year risk	Females	Males
1	0.068%	0.162%
5	0.537%	0.875%
10	1.345%	2.277%
15	2.663%	4.493%
20	4.46%	7.531%

Relationships between endpoints

↥

Index endpoint: H8_INNERNAS – Other specified/unspecified diseases of inner ear

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other specified/unspecified diseases of inner ear

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints